期刊文献+

丁沉透膈散治疗化疗延迟呕吐临床观察 被引量:3

Clinical Observation on Dingchen Touge Powder for Delayed Chemotherapy-induced Vomiting
下载PDF
导出
摘要 目的:观察中药丁沉透膈散治疗肿瘤化疗所致消化道反应的疗效。方法:将136例化疗所致延迟呕吐的患者随机分为2组,在化疗周期中实验组以中药丁沉透膈散汤剂口服;对照组予甲氧氯普胺+地塞米松,比较2组的临床效果与药物不良反应。结果:实验组在治疗食欲不振、抑制恶心、呕吐等方面明显优于对照组,差异有统计学意义(P值均小于0.05)。结论:中药丁沉透膈散防治化疗药物所致消化道反应综合疗效较好,值得临床推广应用。 Objective:To investigate the therapeutic effect of Dingchen Touge powder for chemotherapy induced gastrointestinal reaction.Methods:A total of 136 patients with delayed chemotherapy-induced vomiting were randomly divided into two groups,in chemotherapy cycle,treatment group was given Dingchen Touge powder orally;while control group was given methoxychlor tome amine and dexamethasone.Clinical effect and adverse reaction in two groups were observed and compared.Results:The effect for symptoms of anorexia,nausea and vomiting in treatment group was obviously superior to control group,and the difference was statistically significant(P 0.05).Conclusion:Dingchen Touge powder has good comprehensive effect on chemotherapy-induced gastrointestinal reaction,and is worthy to be clinically popularized and applied.
出处 《世界中医药》 CAS 2013年第8期900-902,共3页 World Chinese Medicine
关键词 丁沉透膈散 化疗 延迟呕吐 Dingchen Touge powder Chemotherapy Delayed vomiting
  • 相关文献

参考文献9

二级参考文献42

  • 1刘叙仪,方红,张辉.呕必停预防化疗所致的胃肠道反应[J].中国新药杂志,1994,3(4):27-29. 被引量:4
  • 2张频,孙燕,张弘刚,王金万,刘晖,董梅,张和平.呕必停预防化疗所致呕吐的临床效果[J].中华肿瘤杂志,1996,18(2):154-156. 被引量:45
  • 3Guideline on non-clinical and clinical development of medical products for the prevention of nausea and vomiting associated with cancer chemotherapy [ C ]. European Medicine Agency ,2006,2-9
  • 4Jorn Herrstedt. The MASCC Evidence Based Clinical Guidelines for Antiemesis [ C]. UICC World Cancer Congress, 2006,29-30
  • 5Kris MG, Hesketh PJ, Somerfield MR et al. American Society of Clinical Oncology guideline for antiemetics in oncology : Update 2006 [ J ]. Clin 0ncol,2006, 24( 18 ) :2932-2947
  • 6Roila F,Hesketh PJ,Herrstedt J, et al. Prevention of chemotherapy-and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetie Consensus Conference [ J ]. Ann Oncol,2006,17 ( 1 ) : 20-28
  • 7NCCN Clinical Practice Guidelines in Oncology : Antiemesis, V. 1. 2007 [ S ]. 1
  • 8Jordan K, Hinke A,Grothey A, et al. A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis [J]. Support Care Cancer,2007,15 : 1023-1033
  • 9Schmoll HJ, Aapro MS, Poli-Bigelli S, et al. Comparison of an aprepitant regimen with a multiple-day ondansetren regimen, both with dexamethasone, for antiemetic efficacy in high-dose eisplatin treatment [J]. Ann Oncol, 2006, 17 (6) :1000-1006
  • 10Jordan K, Schmoll H J, Aapro MS. Comparative activity of antiemetic drugs [ J ]. Crit Rev Oncol Hematol,2007,61 (2) : 162-175

共引文献258

同被引文献27

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部